| HRA006261
(Controlled Access)
|
Our study provided evidence of cellular and molecular levels of involvement in JIA pathogenesis and identified the critical roles for T cells in JIA pathogenesis. Furthermore, our results suggested that there were significant differences in T cell composition and gene expression between HLA-B27+ JIA patients and HLA-B27- JIA patients, which may contribute to the phenotypic differences between HLA-B27-positive and HLA-B27-negative JIA subtypes. Our findings indicated that CCR7+/RELB+/IRF1+ triple positive T cells could damage the cartilage of HLA-B27+ JIA by producing cytokines such as IL-17. Taken together, we believe that CCR7+/RELB+/IRF1+ triple positive T cells capable of producing large amounts of cytokines have the potential to serve as prognostic biomarkers in HLA-B27+ JIA patients. |